IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MUSSONI, LUCIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.385
NA - Nord America 5.547
AS - Asia 5.380
SA - Sud America 418
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 16
Totale 18.830
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.382
GB - Regno Unito 2.805
CN - Cina 1.797
SG - Singapore 1.468
DE - Germania 1.008
IT - Italia 918
SE - Svezia 802
RU - Federazione Russa 580
HK - Hong Kong 409
VN - Vietnam 321
TR - Turchia 314
BR - Brasile 290
FR - Francia 289
IN - India 263
KR - Corea 234
NL - Olanda 231
UA - Ucraina 225
BD - Bangladesh 189
IE - Irlanda 167
EU - Europa 145
JP - Giappone 143
FI - Finlandia 136
CA - Canada 115
PL - Polonia 90
ID - Indonesia 62
PH - Filippine 59
CO - Colombia 53
GR - Grecia 46
BE - Belgio 25
AR - Argentina 21
MX - Messico 21
CI - Costa d'Avorio 20
IQ - Iraq 19
CL - Cile 16
EC - Ecuador 14
SA - Arabia Saudita 13
PK - Pakistan 12
AU - Australia 11
MY - Malesia 10
UZ - Uzbekistan 10
DK - Danimarca 9
ES - Italia 9
CH - Svizzera 8
VE - Venezuela 8
DZ - Algeria 7
KE - Kenya 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
MA - Marocco 6
TH - Thailandia 6
TW - Taiwan 6
ZA - Sudafrica 6
AT - Austria 5
JM - Giamaica 5
JO - Giordania 5
NZ - Nuova Zelanda 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
HU - Ungheria 4
IL - Israele 4
IR - Iran 4
NG - Nigeria 4
PA - Panama 4
RO - Romania 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
ET - Etiopia 3
HN - Honduras 3
KZ - Kazakistan 3
PE - Perù 3
PS - Palestinian Territory 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GT - Guatemala 2
HR - Croazia 2
LT - Lituania 2
ML - Mali 2
MN - Mongolia 2
NO - Norvegia 2
NP - Nepal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
Totale 18.943
Salva come PNG Salva come JPEG
Città #
Southend 2.640
Singapore 808
Ashburn 508
Chandler 404
Hong Kong 399
Beijing 365
San Jose 358
Seattle 314
Wilmington 275
Milan 273
Santa Clara 258
Princeton 253
Hanover 195
Council Bluffs 175
Dublin 165
Redmond 155
Boise 138
Ann Arbor 134
Nanjing 131
Mountain View 130
Jacksonville 125
Dearborn 108
Sakarya 106
Fairfield 102
Los Angeles 99
Bengaluru 97
Munich 97
Lauterbourg 93
New York 93
Dallas 84
Ho Chi Minh City 84
Buffalo 77
Des Moines 77
Serra 77
Moscow 74
Guangzhou 71
Frankfurt am Main 64
Shanghai 64
Somerville 64
Woodbridge 64
Toronto 63
Boardman 62
Hanoi 62
Jinan 62
Andover 56
Warsaw 55
Shenyang 51
Bogotá 48
Grafing 48
Hangzhou 46
Athens 45
Cambridge 45
Centro 45
Hebei 42
Houston 41
Seoul 40
Bitonto 39
Tianjin 39
Changsha 38
Nanchang 38
Berlin 36
Rome 36
Kansas City 35
Eitensheim 34
Zhengzhou 34
São Paulo 33
Tokyo 33
Jakarta 31
Columbus 30
The Dalles 28
Nürnberg 25
Tanggu 25
Brussels 24
Cangzhou 24
Kiez 24
Bühl 23
Helsinki 23
Medford 23
Phoenix 23
Hefei 22
Ottawa 22
Redwood City 21
Fuzhou 20
Abidjan 19
Scranton 18
Taizhou 18
Dong Ket 17
Jiaxing 17
Ningbo 17
Roxbury 17
San Diego 16
Washington 16
Hamburg 14
Kunming 14
Shenzhen 14
Wuhan 13
Haikou 12
Istanbul 12
Naples 12
Pisa 12
Totale 11.650
Salva come PNG Salva come JPEG
Nome #
Effect of valsartan on angiotensin II-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells 445
Pentoxifylline prevents spontaneous brain ischemia in stroke-prone rats 382
Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study 360
D-dimer is associated with arterial and venous coronary artery bypass graft occlusion 304
Minor components of olive oil affect the expression of pro-atherogenic molecules and cGMP-dependent PDE5 activity 280
Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure 265
Effect of n-3 fatty acids on carotid atherosclerosis and hemostasis in hypertriglyceridemic patients: a double blind pilot study in primary prevention 257
Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery 253
Cytokines present in smokers' serum interact with smoke components to enhance endothelial dysfunction 243
Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group 236
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group 234
Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL 234
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study 234
Effect of n-3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: a double-blind pilot study in primary prevention 229
Effect of omega-3 PUFA on carotid IMT and haemostasis in hypertriglyceridemic patients: a longitudinal pilot study in primary prevention 227
Antithrombotic and anti-inflammatory properties of rosuvastatin in cultured human endothelial cells 225
Gender differences in endothelial function and inflammatory markers along the occurrence of pathological events in stroke-prone rats 221
Minor components of olive oil modulate proatherogenic adhesion molecules involved in endothelial activation 220
Lipoproteine aterogene e sintesi di PAI-1 da parte di cellule endoteliali 220
Rosuvastatin exerts renoprotective effects in stroke-prone rats independently of changes in cholesterol levels 218
Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro 217
La rosuvastatina previene il danno renale spontaneo nei ratti SHRSP modulando il sistema plasminogeno/plasmina e l’espressione delle metalloproteasi 216
Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up 213
Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats 212
The ATROCAP Study: atorvastatin and the thrombogenicity of carotid atherosclerotic plaque 212
Rosuvastatin exerts renoprotective effects in stroke-prone rats by modulating the plasminogen/plasmin system and the metalloproteases expression 211
Distinct roles for PAR1- and PAR2-mediated vasomotor modulation in human arterial and venous conduits 211
Nonrheumatic calcific aortic stenosis : an overview from basic science to pharmacological prevention 210
Generation and characterization of a stable rat adult brain endothelial cell line 210
Mitochondrial reactive oxygen species : a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells 207
LDL-acetilate e sintesi di PAI-1 da parte di cellule endoteliali: ruolo del recettore scavenger 207
Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts 205
Proteomic analysis of plasma from patients undergoing coronary artery bypass grafting reveals a protease/antiprotease imbalance in favor of the serpin alpha1-antichymotrypsin 205
Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemia 204
Lipoproteine aterogene e trombosi: aspetti cellulari 203
Proteome of platelets in patients with coronary artery disease 202
Additive effect of triglyceride and insulin as determinants of plasminogen activator inhibitor-1 levels in normo and hypertriglyceridemic subjects 202
Prostacyclin reduction results in tissue factor (TF) upregulation and predisposes cyclooxygenase-2 knockout (COX-2KO) mice to thrombosis 201
Isoprostanes and oxidative stress in off-pump and on-pump coronary bypass surgery 196
Vascular thrombogenicity induced by progressive LDL oxidation : protection by antioxidants 195
Tissue factor induction by protease-activated receptor 1 requires intact caveolin-enriched membrane microdomains in human endothelial cells 190
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 190
Proteomic analysis of plasma from patients undergoing coronary artery bypass grafting reveals a protease/anti-protease imbalance in favor of the serpin alpha1-antichymotrypsin 190
Expression of alternatively spliced tissue factor in human endothelial cells : induction by inflammatory stimuli and modulation by heparins 185
Effects of native and modified low density lipoproteins on functional and biochemical aspects of cells involved in the thrombotic process 181
Proteome of endothelial cell-derived procoagulant microparticles 179
Atherosclerotic plaque as a therapeutic target. The ATROCAP Study (Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque). 177
The role of tissue factor and P-selectin in the procoagulant response that occurs in the first month after on-pump and off-pump coronary artery bypass grafting 175
Triglycerides and the fibrinolytic system 175
Triglycerides and the fibrinolytic system 174
Plasminogen activator inhibitor type-1 mRNA expression is increased by triglyceride rich lipoproteins in human hepatoma cells 174
Rosuvastatin exerts renoprotective effects in stroke-prone rats by modulating the plasminogen/plasmin system and metalloproteases expression 170
Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway 170
Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon 169
Oxidized LDLs influence thrombotic response and cyclooxygenase 2 166
Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells 166
Rosuvastatin exerts renoprotective effects in stroke-prone rats modulating the plasminogen/plasmin and metalloprotease systems 164
Distinct roles for PAR-1 and PAR-2 mediated vasomotor modulation in human arterial and venous conduits used in coronary artery bypass surgery 162
REGULATION OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 BY ACETYL-LDL IN HUMAN UMBIUCAL VEIN ENDOTIIELIAL CELLS 162
Proteome of endothelial cell-derived procoagulant microparticles 160
Parnaparin reduces the extent of damage in rat brain ischemia : a nuclear magnetic resonance imaging study 160
Protease-activated receptors 1 and 2 activation induces tissue factor through mitochondrial reactive oxygen species 160
Effect of atorvastatin on coagulation and inflammatory variables in patients with bilateral carotid stenosis. 159
Atherogenic lipoproteins and PAI-1 synthesis by endothelial-cells 159
Lipoproteine aterogene ed endotelio vascolare 158
Inhibition of cholesterol biosynthesis as a new antithrombotic strategy 157
Effect of omega-3 PUFA on carotid IMT and hemostasis in hypertriglyceridemic patients: a longitudinal pilot study in primary prevention 156
Effects of triglyceride rich lipoproteins on the synthesis of plasminogen activator inhibitor 1 (PAI-1) by HepG2 cells 156
Hypertriglyceridemia and regulation of fibrinolytic activity 155
Induzione del PAI-1 da parte di VLDL in cellule HEPG2: meccanismi di trasduzione 155
Effetto delle VLDL sull'espressione di mRNA per il PAI-1 in cellule HepG2 152
Hyperlipidemias and the fibrinolytic system 151
Additive effect of triglyceride and insulin as determinants of plasminogen activator inhibitor-1 levels in normo and hypertriglyceridemic subjects 151
Distinct roles for PAR1 and 2-mediated vasomotor modulation in human arterial and venous conduits used in coronary artery by pass surgery 151
Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells 150
An increased prothrombotic state lasts up to one month after on-pump and off-pump coronary surgery 150
Triglycerides and the fibrinolytic system: in vitro regulation of the synthesis of plasminogen activator type 1 by triglyceride-rich lipoproteins in HepG2 cells 149
Effect of triglycerides and triglyceride rich lipoproteins on fibrinolytic system 146
Effect of atherogenic lipoproteins on PAI-1 synthesis by endothelial cells 145
Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery 142
Protein-Kinase-C inhibitors and gemfibrozil prevent the enhancing effect of very low density lipoproteins on the biosynthesis of plasminogen activator inhibitor type 1 by HepG2 cells 142
Triglycerides as predictor of tissue activator and of tissue plasminogen activator inhibitor type 1 levels in non obese normo and hypertriglyceridemic subjects 138
Antithrombotic and antiinflammatory properties of rosuvastatin in cultured human endothelial cells. 137
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 136
Antithrombotic and antiinflammatory properties of rosuvastatin in culured human endothelial cells 135
Fibrinolytic variables in atherosclerotic patients-comparison between patients with and without peripheral arterial-disease (PAD) 133
PAR-1 and PAR-2 activation mediates tissue factor induction in endothelial cells through a redox-sensitive signaling pathway 132
Endothelial tissue factor induction by T lymphocytes in systemic sclerosis 131
Neurohormonal activation is associated with increased levels of plasma MMP-2 in human heart failure 130
Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts 129
Increased thrombogenic potential of human monocyte-derived macrophages spontaneously transformed into foam cells 129
Fibrinolytic variables in prediction of atherothrombotic sequelae in patients with preexisting vascular ischaemic disease : the plat study 128
Tissue factor induction by protease-activated receptor-1 requires intact caveolin-enriched membrane microdomains in human endothelial cells 127
Tissue factor expression and apoptosis induced by oxidised low density lipoptoteins on human umbilical endothelials cells are prevented by antioxidants 126
Influence of atherogenic lipoproteins on the thrombotic potential of endothelial cells 126
n-3 PUFA which mechanisms? 126
Endogenous proteolytic activity in a rat model of spontaneous cerebral stroke 125
The effect of synthetic malaria pigment (beta-haematin) on adhesion molecule expression and interleukin-6 production by human endothelial cells 124
Effects of protein kinase C inhibitors and of gemfibrozil on the biosynthesis of plasminogen activator inhibitor type 1 by HepG2 cells exposed to very low density lipoproteins 119
Farmaci fibrinolitici 117
Totale 18.557
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.012
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.012
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021498 0 0 0 0 0 0 0 0 0 0 408 90
2021/20221.523 132 69 96 107 96 165 112 80 106 122 208 230
2022/20231.587 285 164 127 194 148 302 41 82 131 27 66 20
2023/2024918 35 80 51 59 218 126 18 48 23 55 83 122
2024/20252.193 70 190 27 259 303 78 51 234 112 199 148 522
2025/20264.371 448 178 433 325 442 343 468 277 554 433 470 0
Totale 19.889